CSChunyi Sun

Chunyi Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chunyi Sun has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Changjun Xu

    Department of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming Yunnan, China

    3 shared publications
  • Daizhu Li

    Department of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming Yunnan, China

    3 shared publications
  • Honglin Zhou

    Department of Gynecology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China

    3 shared publications
  • Qing Qing

    Department of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming Yunnan, China

    3 shared publications
  • Yajuan Huang

    Department of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming Yunnan, China

    3 shared publications
  • Yang Liu

    Department of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming Yunnan, China

    3 shared publications

Latest Publications

  • Open Access

    HPV infection screening using surface plasmon resonance in women from Kunming (Southwest China)

    by Yang Liu, Yue Quan, Changjun Xu, Yajuan Huang, Daizhu Li, Qing Qing, Chunyi Sun, Honglin Zhou

    No study examined the frequency of human papillomavirus (HPV) genotypes by surface plasmon resonance (SPR) in Southwest China. This was a cross-sectional survey (The Second Affiliated Hospital of Kunming Medical University, 10/2010 to 12/2011) in 150 patients who were hospitalized or volunteered for cervical cancer (CC) screening. A HPV typing kit was used to detect 24 types of HPV by the SPR technique. The HPV-positive rate was 34.8% in women with normal cytology and 92.9% in women with CC. The frequency of HPV16 increased from 9.4% for women with normal cytology to 28.9% for cervical intraepithelial neoplasia (CIN)1, 41.4% for CIN2, 54.1% for CIN3, and 71.4% for CC (p < 0.001). The frequency of HPV18 increased from 0% for women with normal cytology to 2.6% for CIN1, 3.4% for CIN2, 5.4% for CIN3, and 21.4% for CC (p = 0.03). HPV40 was only found in one patient with CC (p = 0.04). There was no relation between HPV genotype and women’s age. In Kunming (Southwest China), the frequency of HPV infection was 74.0% among women who underwent CC screening. HPV16 and HPV18 were the two most frequent genotypes. SPR could be of value for the screening of HPV infection.

  • Open Access

    Chlamydia trachomatis and mycoplasma infections in tubal pregnancy

    by Yang Liu, Yunjiang Zhang, Dehong Yang, Changjun Xu, Yajuan Huang, Qing Qing, Daizhu Li, Jing Liao, Yulu Ding, Jiaoyue Zhou, et al.

    Chlamydia trachomatis (CT) infection is an important factor for tubal pregnancy. However, whether Ureaplasma urealyticum (UU) and Mycoplasma hominis (MH) infections are also involved in tubal pregnancy remains unknown. This study is aimed to detect CT, UU, and MH in cervical secretions from patients with tubal pregnancy and control women in early pregnancy, to explore their prevalence rates and drug susceptibilities. Analysis was performed on patients with tubal pregnancy and those requiring termination of early pregnancy at <12 weeks from July 2013 to March 2014. Cervical secretions were tested for UU/MH with a UU/MH isolation and culture kit and for CT antigen by an immunochromatographic assay. Mycoplasma samples were tested for resistance to 12 antibiotics. There were no cases of CT infection detected. Mycoplasma infection rates (single or mixed) were similar in the tubal pregnancy and control groups, but the total rate of infection was higher for tubal pregnancy. All MH samples were sensitive to tetracyclines as well as josamycin and azithromycin. Josamycin and clarithromycin were effective against all UU cultures. Over 50% of the samples tested were resistant to ciprofloxacin.


  • Open Access

    Human papillomavirus and human telomerase RNA component gene in cervical cancer progression

    by Yang Liu, Pianping Fan, Yingying Yang, Changjun Xu, Yajuan Huang, Daizhu Li, Qing Qing, Chunyi Sun, Honglin Zhou

    This study aimed to examine hTERC gene in different grades of cervical intraepithelial neoplasia (CIN) and cervical cancer, and the association between hTERC and high risk-human papillomavirus (HR-HPV) infection. Patients who underwent cervical cancer screening at the Second Affiliated Hospital of Kunming Medical University between October 2010 and December 2011 were enrolled. All patients underwent liquid-based cytology test and hybrid capture 2 (HC2) for HPV detection. hTERC was examined using fluorescence in situ hybridization (FISH). Cervical colposcopy biopsy was performed if any of the three results was positive. HC2, FISH, and pathology were compared. A total of 1200 women underwent screening, 150 patients underwent cervical biopsy: 32 in the normal group, 38 in the CIN1 group, 66 in the CIN2/3 group, and 14 in the invasive cervical cancer group. More patients had HR-HPV infection in the CIN2/3 group and ICC group compared with the CIN1 group. hTERC increased with increasing histological dysplasia. There was significant difference in hTERC positive rate between each of the three groups. More patients with hTERC gene amplification were observed in the positive HR-HPV group than in the HR-HPV negative group. In conclusion, hTERC is a potential marker for precancerous cervical cancer lesions. hTERC might be correlated with HR-HPV infection in cervical diseases.